Issues occult hepatitis B virus infection
Abstract
Aim of investigation. With the help of up-to-date molecular-biological and morphological methods to determine frequency of the occult form of chronic hepatitis B (CHB) among HBsAg-negative patients with chronic liver diseases (CLD) of various etiology and to present clinical and morphological characteristic.
Material and methods. Overall 168 patients were investigated. Of 60 patients with anti-HBcAg antibodies 35 patients without HBsAg and DNA HBV in blood serum have been selected, who underwent fine-needle transcutaneous liver biopsy. Molecular biologic enzymelinked immunoassay (ELISA), polymerase chain reaction (PCR) and morphological (immunohistochemistry, electron microscopy) methods were utilized for diagnostics.
Results. Novel two-stage algorithm of diagnostics of CHB occult form was developed. Morphological criteria, typical for obscure HBV-monoinfections and HCV coinfection are described. With the help of immunohistochemistry and electron microscopy in all patients with anti-HBcAg antibodies in serum and absence of HBsAg and DNA HBV, presence of HBV virions in liver tissue was revealed. HBV and HCV coinfection was accompanied by more severe (in comparison to monoinfection) immune inflammatory response. In 80% of cases presence of TT-like mini virus (TTMV) in blood lymphoid elements was revealed, in two patients this virus was detected in hepatocyte nucleus that proves its hepatotropic properties.
Conclusions. Frequency of the occult form of hepatitis B among CLD patients is no less than 20%. It was found, that anti-НВсAg antibodies can be effective, though «surrogate» marker of HBV-infection.
About the Authors
I. A. MorozovRussian Federation
L. Yu. Ilchenko
Russian Federation
N. I. Gromova
Russian Federation
I. G. Fyedorov
Russian Federation
I. V. Gordeychuk
Russian Federation
A. K. Knyazhentseva
Russian Federation
E. V. Zverkova
Russian Federation
M. I. Mikhaylov
Russian Federation
References
1. Вирусные гепатиты в Российской Федерации 2009: Аналитический обзор / Под ред. Г.Г. Онищенко, А.Б. Жебруна. – СПб: НИЭМ им. Пастера, 2009. – C. 17–41.
2. Гордейчук И.В. Выявление и клинико-морфологическая характеристика скрытой ВГВ-инфекции среди HBsAg-негативных пациентов с хроническими заболеваниями печени // Дальневосточный журнал инфекционной патологии. – 2010. – № 17. – С. 42–49.
3. Морозов И.А., Ильченко Л.Ю., Кюрегян К.К. и др. Латентная HBV-инфекция и алгоритм ее выявления у пациентов с хроническими заболеваниями печени // В мире вирусных гепатитов. – 2011. – № 1. – С. 19–26.
4. Шахгильдян И.В., Михайлов М.И., Онищенко Г.Г. Парентеральные вирусные гепатиты (эпидемиология, диагностика, профилактика). – М.: ФГОУ «ВУНМЦ Росздрава», 2003. – С. 22–27.
5. Basuni A.A., Carman W.L. HBV vaccine-escape i variants // Methods Mol. Med. – 2004. – Vol. 95. – P. 115–124.
6. Cacciola I., PollicinoT., Squadrito G. et al. Occult hepatitis В virus infection in patients with chronic hepatitis С liver disease // NEJM. – 1999. – Vol. 341. – P. 22–26.
7. Carman W.F. The clinical significance of surface antigen variants of hepatitis B virus // J. Viral Hepatol. – 1997. – Vol. 4. – P. 11–20.
8. Castillo I., Rodriguez-lcigo E., Lypez-Alcorocho J. et al. Comparative study on the clinical and virological characteristics among patients with single occult hepatitis В virus (HBV), single occult hepatitis С virus (HCV) and occult HBV and HCV dual infection // J. Med. Virol. – 2007. – Vol. 3. – P. 236–241.
9. Hausen H., de Villiers E.M. Virus target cell conditioning model to explain some epidemiologic characteristics of childhood leukemias and lymphomas // Int. J. Cancer. – 2005. – Vol. 115. – P. 1–5.
10. Hollinger F.B. Hepatitis B virus infection and transfusion medicine: science and the occult // Transfusion. – 2008. – Vol. 48. – P. 1001–1026.
11. Hollinger F.B., Sood G. Occult hepatitis В virus infection: a covert operation // J. Viral. Hepat. – 2010. – Vol. 17. – P. 1–15.
12. Jeantet D., Chemin I., Mandrand B. et al. Cloning and expression of surface antigens from occult chronic hepatitis В virus infections and their recognition by commercial detection assays // J. Med. Virol. – 2004. – Vol. 73. – P. 508–515.
13. Moriyama M., Matsumura H., Shimizu T. et al. Histopathologic impact of TT virus infection on the liver of type C chronic hepatitis and liver cirrhosis in Japan // J. Med. Virol. – 2001. – Vol. 64. – P. 74–81.
14. Ninomiya M., Takahashi M., Nishizava T. et al. Development of PCR assays with nested primers specific for differential detection of the three human anelloviruses and early acquisition of dual or triple infection during infancy // J. Clin. Microbiol. – 2008. – Vol. 46. – P. 507–514.
15. Raimondo G., Navarra G., Mondello S. et al. Occult hepatitis B virus in liver tissue of individuals without hepatic disease // J. Hepatol. – 2008. – Vol. 48. – P. 743–746.
Review
For citations:
Morozov I.A., Ilchenko L.Yu., Gromova N.I., Fyedorov I.G., Gordeychuk I.V., Knyazhentseva A.K., Zverkova E.V., Mikhaylov M.I. Issues occult hepatitis B virus infection. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2012;22(4):58-65. (In Russ.)
Views:
85
Email this article 
